The stock of Evolus Inc (EOLS) has seen a 2.26% increase in the past week, with a 27.46% gain in the past month, and a 25.54% flourish in the past quarter. The volatility ratio for the week is 3.30%, and the volatility levels for the past 30 days are at 4.26% for EOLS. The simple moving average for the last 20 days is 10.98% for EOLS stock, with a simple moving average of 29.84% for the last 200 days.
Is It Worth Investing in Evolus Inc (NASDAQ: EOLS) Right Now?
The stock has a 36-month beta value of 1.30. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for EOLS is 54.45M, and at present, short sellers hold a 8.85% of that float. On August 30, 2024, the average trading volume of EOLS was 507.71K shares.
EOLS) stock’s latest price update
Evolus Inc (NASDAQ: EOLS) has seen a decline in its stock price by -0.06 in relation to its previous close of 15.84. However, the company has experienced a 2.26% gain in its stock price over the last five trading sessions. businesswire.com reported 2024-08-09 that NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in July an aggregate of 46,363 restricted stock units (RSUs) of the company’s common stock to 16 newly hired non-executive employees of the company (the “July Grants”). The Company also is reporting the grant in August of an aggregate of 35,921 RSUs and non-qualified stock options to purchase an aggregate o.
Analysts’ Opinion of EOLS
Many brokerage firms have already submitted their reports for EOLS stocks, with Barclays repeating the rating for EOLS by listing it as a “Overweight.” The predicted price for EOLS in the upcoming period, according to Barclays is $16 based on the research report published on January 29, 2024 of the current year 2024.
Needham, on the other hand, stated in their research note that they expect to see EOLS reach a price target of $18. The rating they have provided for EOLS stocks is “Buy” according to the report published on June 23rd, 2022.
Barclays gave a rating of “Equal Weight” to EOLS, setting the target price at $10 in the report published on May 12th of the previous year.
EOLS Trading at 25.76% from the 50-Day Moving Average
After a stumble in the market that brought EOLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.82% of loss for the given period.
Volatility was left at 4.26%, however, over the last 30 days, the volatility rate increased by 3.30%, as shares surge +12.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +48.78% upper at present.
During the last 5 trading sessions, EOLS rose by +2.26%, which changed the moving average for the period of 200-days by +97.88% in comparison to the 20-day moving average, which settled at $14.35. In addition, Evolus Inc saw 50.33% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EOLS starting from MOATAZEDI DAVID, who sale 175,940 shares at the price of $12.59 back on Jun 06 ’24. After this action, MOATAZEDI DAVID now owns 533,349 shares of Evolus Inc, valued at $2,214,486 using the latest closing price.
MOATAZEDI DAVID, the of Evolus Inc, sale 155,278 shares at $12.92 during a trade that took place back on Jun 05 ’24, which means that MOATAZEDI DAVID is holding 533,349 shares at $2,006,456 based on the most recent closing price.
Stock Fundamentals for EOLS
Current profitability levels for the company are sitting at:
- -0.14 for the present operating margin
- 0.68 for the gross margin
The net margin for Evolus Inc stands at -0.22. The total capital return value is set at -0.18. Equity return is now at value -861.68, with -26.42 for asset returns.
Based on Evolus Inc (EOLS), the company’s capital structure generated 0.86 points at debt to capital in total, while cash flow to debt ratio is standing at -0.42. The debt to equity ratio resting at 6.31. The interest coverage ratio of the stock is -108.35.
Currently, EBITDA for the company is -30.24 million with net debt to EBITDA at -0.99. When we switch over and look at the enterprise to sales, we see a ratio of 4.36. The receivables turnover for the company is 5.48for trailing twelve months and the total asset turnover is 1.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.92.
Conclusion
To sum up, Evolus Inc (EOLS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
